0001437749-24-013866.txt : 20240430
0001437749-24-013866.hdr.sgml : 20240430
20240430091343
ACCESSION NUMBER: 0001437749-24-013866
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240426
FILED AS OF DATE: 20240430
DATE AS OF CHANGE: 20240430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBERTSON SANFORD
CENTRAL INDEX KEY: 0001250105
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41905
FILM NUMBER: 24894256
MAIL ADDRESS:
STREET 1: ONE LETTERMAN DRIVE
STREET 2: BUILDING C SUITE 410
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASSAVA SCIENCES INC
CENTRAL INDEX KEY: 0001069530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 911911336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: BUILDING 1; SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78731
BUSINESS PHONE: 512-501-2444
MAIL ADDRESS:
STREET 1: 6801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: BUILDING 1; SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78731
FORMER COMPANY:
FORMER CONFORMED NAME: PAIN THERAPEUTICS INC
DATE OF NAME CHANGE: 20000309
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-04-26
0001069530
CASSAVA SCIENCES INC
SAVA
0001250105
ROBERTSON SANFORD
6801 N CAPITAL OF TEXAS HWY, BLDG 1
SUITE 300
AUSTIN
TX
78731
1
0
Common Stock
2024-04-26
4
M
0
69000
22
A
955851
D
Common Stock
180000
I
By family
Common Stock Warrant
33
2024-01-03
4
A
0
72000
0
A
2024-01-03
2024-05-07
Common Stock
108000
72000
I
By family
Common Stock Warrant
33
2024-01-03
4
A
0
354740
0
A
2024-01-03
2024-05-07
Common Stock
532110
354740
D
Common Stock Warrant
33
2024-04-26
4
M
0
46000
0
D
2024-01-03
2024-05-07
Common Stock
69000
308740
D
Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.
Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised.
/s/ Eric J. Schoen by Power of Attorney
2024-04-30